BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9435156)

  • 1. Differential effects of salbutamol and salmeterol on human eosinophil responses.
    Ezeamuzie CI; al-Hage M
    J Pharmacol Exp Ther; 1998 Jan; 284(1):25-31. PubMed ID: 9435156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of salmeterol on human eosinophils is both stimulus- and response-dependent.
    Ezeamuzie CI; al-Hage M; Nwankwoala RN
    Int J Immunopharmacol; 1997 Aug; 19(8):421-30. PubMed ID: 9568547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of some anti-asthma drugs on human eosinophil superoxide anions release and degranulation.
    Ezeamuzie CI; Al-Hage M
    Int Arch Allergy Immunol; 1998 Feb; 115(2):162-8. PubMed ID: 9482706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of salbutamol and montelukast on eosinophil adhesion and superoxide anion generation.
    Kushiya M; Saito K; Kikuchi I; Kobayashi T; Hagiwara K; Kanazawa M; Nagata M
    Int Arch Allergy Immunol; 2006; 140 Suppl 1():17-22. PubMed ID: 16772722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of short-acting beta2-agonists on human granulocyte functions.
    Yasui K; Kobayashi N; Yamazaki T; Agematsu K; Matsuzaki S; Nakata S; Baba A
    Int Arch Allergy Immunol; 2006; 139(1):1-8. PubMed ID: 16272820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by fenoterol of human eosinophil functions including beta2-adrenoceptor-independent actions.
    Tachibana A; Kato M; Kimura H; Fujiu T; Suzuki M; Morikawa A
    Clin Exp Immunol; 2002 Dec; 130(3):415-23. PubMed ID: 12452831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of salmeterol and nimesulide on chemotaxis and synthesis of PAF and LTC4 by human eosinophils.
    Tool AT; Mul FP; Knol EF; Verhoeven AJ; Roos D
    Eur Respir J Suppl; 1996 Aug; 22():141s-145s. PubMed ID: 8871060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical blockade of beta adrenergically mediated inhibition of stimulated eosinophil secretion by salmeterol.
    Muñoz NM; Rabe KF; Vita AJ; McAllister K; Mayer D; Weiss M; Leff AR
    J Pharmacol Exp Ther; 1995 May; 273(2):850-4. PubMed ID: 7752089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophil adhesion to vascular cell adhesion molecule-1 activates superoxide anion generation.
    Nagata M; Sedgwick JB; Bates ME; Kita H; Busse WW
    J Immunol; 1995 Aug; 155(4):2194-202. PubMed ID: 7543540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GM-CSF regulates human eosinophil responses to F-Met peptide and platelet activating factor.
    Tomioka K; MacGlashan DW; Lichtenstein LM; Bochner BS; Schleimer RP
    J Immunol; 1993 Nov; 151(9):4989-97. PubMed ID: 8409452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of beta2-adrenergic agonists on eosinophil adhesion, superoxide anion generation, and degranulation.
    Noguchi T; Nakagome K; Kobayashi T; Ueda Y; Soma T; Nakamoto H; Nagata M
    Allergol Int; 2015 Sep; 64 Suppl():S46-53. PubMed ID: 26344080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of terfenadine on human eosinophil and neutrophil chemotactic response and generation of superoxide.
    Eda R; Townley RG; Hopp RJ
    Ann Allergy; 1994 Aug; 73(2):154-60. PubMed ID: 8067599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug modulation of superoxide anion production from human neutrophils.
    Fantozzi R; Brunelleschi S; Cremonesi P; Pagella PG; Ciani D; Sportoletti GC
    Int J Tissue React; 1985; 7(2):149-52. PubMed ID: 2863232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The duration of action of non-beta 2-adrenoceptor mediated responses to salmeterol.
    Nials AT; Coleman RA; Johnson M; Vardey CJ
    Br J Pharmacol; 1997 Mar; 120(5):961-7. PubMed ID: 9138705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salmeterol decreases eosinophilic cationic protein and rescue medication in patients inhaling beclomethasone dipropionate: preliminary study in mild and moderate asthma in Trinidad, West Indies.
    Pinto Pereira LM; Clement Y; Rouse J; Matthew J; Asgarali Z; Ramoutar D; Teelucksingh S
    Int J Clin Pharmacol Res; 2003; 23(2-3):69-74. PubMed ID: 15025036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4.
    Blease K; Burke-Gaffney A; Hellewell PG
    Br J Pharmacol; 1998 May; 124(1):229-37. PubMed ID: 9630364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet-activating factor.
    Kimani G; Tonnesen MG; Henson PM
    J Immunol; 1988 May; 140(9):3161-6. PubMed ID: 3361129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung.
    Whelan CJ; Johnson M; Vardey CJ
    Br J Pharmacol; 1993 Oct; 110(2):613-8. PubMed ID: 7902175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta adrenergic modulation of formyl-methionine-leucine-phenylalanine-stimulated secretion of eosinophil peroxidase and leukotriene C4.
    Munoz NM; Vita AJ; Neeley SP; McAllister K; Spaethe SM; White SR; Leff AR
    J Pharmacol Exp Ther; 1994 Jan; 268(1):139-43. PubMed ID: 8301549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential control of TH1 versus TH2 cell responses by the combination of low-dose steroids with beta2-adrenergic agonists.
    Goleva E; Dunlap A; Leung DY
    J Allergy Clin Immunol; 2004 Jul; 114(1):183-91. PubMed ID: 15241363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.